|17.45|| +0.10 / +0.58%|
Meridian Bioscience, Inc. is a fully integrated life science company, which engages in the development, manufacture, sale, and distribution of diagnostic test kits, purified reagents, and related products and offers biopharmaceutical enabling technologies. It operates in the Diagnostics and Life Science segments. The Diagnostics segment comprises of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the US, Europe, Africa and the Middle East. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia and the sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bioresearch reagents domestically and abroad. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.
|John A. Kraeutler||Chairman & Chief Executive Officer|
|Lawrence J. Baldini||Executive VP & President-Global Operations|
|Melissa A. Lueke||Chief Financial Officer, Secretary & EVP|
|Vecheslav A. Elagin||Executive Vice President-Research & Development|
|Richard L. Eberly||Executive Vice President|